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Question: My patient developed a fever during a packed red blood cell transfusion. What is the 
likelihood that the fever is due to bacterial contamination of the blood product? 
 
 
Answer: Fever is a common feature of 
many different types of transfusion 
reactions, including febrile non hemolytic 
transfusion reaction (FNHTR), acute and 
delayed hemolytic transfusion reactions, 
transfusion related acute lung injury 
(TRALI), transfusion associated graft vs 
host disease, and microbial contamination of 
the blood product. Of these types of 
reactions, FNHTR is the most common and 
is generally considered to be a benign and 
self-limited type of reaction.  While the 
remaining reaction types occur much less 
frequently, they are much more serious and 
may be associated with significant morbidity 
and mortality
1
.  
Sepsis secondary to transfusion of 
contaminated blood products is considered a 
very rare event. From 1976 to 1998, the U.S. 
Food and Drug Administration (FDA) 
received reports of 26 fatalities thought to be 
from contaminated whole blood or red 
cells
2
. The most common culprits in 
contaminated red blood cell units are Gram 
negative bacilli, which are thought to 
originate from transient bacteremia during 
blood donation in an otherwise 
asymptomatic blood donor.  This may also 
occur after dental manipulation or even 
tooth brushing. 
Platelets have a higher rate of 
bacterial contamination than red blood cell 
units, as they are stored at room temperature 
with constant agitation which is conducive 
to microbial growth.  A wide range of 
bacteria have been documented in platelet 
products, but Gram positive skin flora are 
seen most commonly.  While Gram negative 
organisms are rare in platelet products, when 
present they are associated with increased 
mortality
3
.  
Introduction of a diversion pouch 
during apheresis platelet collection and 
mandatory bacterial culture for all platelet 
units 24 hours after collection has resulted in 
a dramatic decrease in the risk of bacterial 
contamination of platelet units
2
.  It is now 
estimated that approximately 1 in 6000 
platelet units are contaminated with bacteria 
and 1 in 100,000 platelet units will cause a 
septic transfusion reaction.  Fatalities from 
bacterially contaminated platelets are 
estimated to occur in 1 in 500,000 platelet 
transfusions
4
.   
In 2016, the FDA issued a draft 
guidance proposing additional measures to 
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address the residual risk of bacterial 
contamination. Two possible approaches 
were suggested: pathogen reduction (PR) 
technology and secondary bacterial testing 
(SBT) methods
3
. As this guidance has not 
been finalized at this time, many blood 
banks have yet to implement either of these 
additional strategies. 
The key to diagnosing transfusion 
related sepsis is culturing the same organism 
from the patient and from the residual 
transfused blood product. Gram stain of the 
suspected blood product bag may be 
performed at the time of the transfusion 
reaction, but has a low sensitivity in this 
setting.  Visual inspection of the unit 
including color changes and frothiness are 
important clues.  
In conclusion, though rare, 
transfusion related sepsis can be a potential 
cause for fever during transfusion and 
consequently a cause for increased 
morbidity and mortality in patients. 
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